APA

Tai H. L., Fessing M. Y., Bonten E. J., Yanishevsky Y., d'Azzo A., Krynetski E. Y. & Evans W. E. (20000106). Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. : Pharmacogenetics.

Chicago

Tai H L, Fessing M Y, Bonten E J, Yanishevsky Y, d'Azzo A, Krynetski E Y and Evans W E. 20000106. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. : Pharmacogenetics.

Harvard

Tai H. L., Fessing M. Y., Bonten E. J., Yanishevsky Y., d'Azzo A., Krynetski E. Y. and Evans W. E. (20000106). Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. : Pharmacogenetics.

MLA

Tai H L, Fessing M Y, Bonten E J, Yanishevsky Y, d'Azzo A, Krynetski E Y and Evans W E. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. : Pharmacogenetics. 20000106.